Ellen Goldberg
Direktor/Vorstandsmitglied bei CASTLE BIOSCIENCES, INC.
Vermögen: 185 443 $ am 30.04.2024
Aktive Positionen von Ellen Goldberg
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CASTLE BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 16.07.2021 | - |
| Independent Dir/Board Member | 16.07.2021 | - |
Karriereverlauf von Ellen Goldberg
Ehemalige bekannte Positionen von Ellen Goldberg
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Crescendo Bioscience LLC
 Crescendo Bioscience LLC Miscellaneous Commercial ServicesCommercial Services Crescendo Bioscience, Inc. develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases. It develops quantitative, objective, reproducible blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. The company was founded by Mike B. Centola and Christopher L. Sutton in July 2002 and is headquartered in South San Francisco, CA. | Vertrieb & Marketing | 01.01.2009 | 01.01.2011 |
Ausbildung von Ellen Goldberg
| Stanford University | Graduate Degree |
| Yale University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
| Graduate Degree | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 2 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CASTLE BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Crescendo Bioscience LLC
Crescendo Bioscience LLC Miscellaneous Commercial ServicesCommercial Services Crescendo Bioscience, Inc. develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases. It develops quantitative, objective, reproducible blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. The company was founded by Mike B. Centola and Christopher L. Sutton in July 2002 and is headquartered in South San Francisco, CA. | Commercial Services |
- Börse
- Insiders
- Ellen Goldberg
- Erfahrung
